Company / Income Tax
Olema Pharmaceuticals, Inc. Income Tax History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$2.0K
FY2024
5-year range
$1.0K / $2.0K
FY2022-FY2024
Trend
+0.0%
vs FY2023
Sector context
#115 of 204
Health Care
What the data says
At $2,000, Olema Pharmaceuticals, Inc.'s income tax ranks #90 of 204 in the Health Care sector. Increased from $1,000 to $2,000 over the past 2 years.
Based on SEC 10-K filings.
$2,000 in FY2024.
Increased from $1,000 to $2,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 204 in Health CareTop 44% of 204This company $2.0K Sector average $118.7M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, income tax increased 0.0% year-over-year.
- Ranks #115 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.0K | +0.0% |
| FY2023 | $2.0K | +100.0% |
| FY2022 | $1.0K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026